Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

1.2K
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.2K
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

400
Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
400
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

553
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
553
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

303
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
303
Peripheral Artery Disease IV: Nursing Management01:26

Peripheral Artery Disease IV: Nursing Management

398
 The nursing management of a patient with peripheral artery disease (PAD) begins with a thorough assessment of the patient’s health history and clinical manifestations.AssessmentHealth History: Evaluate the patient’s history of hypertension, hyperlipidemia, family history of cardiovascular issues, and lifestyle factors such as dietary patterns, smoking, and physical activity.Physical Examination:Assess the affected extremity for decreased or absent peripheral pulses,...
398
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

424
Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
424

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Venous thromboembolism in patients with breast, ovarian, and uterine cancer. A comparative analysis from the Registro Informatizado Enfermedad TromboEmbólica registry.

Research and practice in thrombosis and haemostasis·2026
Same author

Effect of a home-based calf neuromuscular electrical stimulation program on walking capacity in adults with lower-extremity PAD: the ELECTRO-PAD RCT.

European journal of preventive cardiology·2026
Same author

Generation of Motional Squeezed States for Neutral Atoms in Optical Tweezers.

Physical review letters·2026
Same author

lncRNA LINC-PINT controls lymphatic function and inflammatory profile in lymphedema.

Science advances·2025
Same author

Sex and Age Differences in Suspected Bleeding Reporting With Acetyl Salicylic Acid: A Descriptive Study in the Global Pharmacovigilance Database, Vigibase.

Fundamental & clinical pharmacology·2025
Same author

Prediction of Chronic Limb Threatening Ischemia by Clinical Data: The PREDICCMI Study.

Annals of vascular surgery·2025

Related Experiment Video

Updated: Feb 15, 2026

Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease
06:16

Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease

Published on: August 9, 2024

971

[Lower-extremity artery disease (LEAD)].

Alessandra Bura-Rivière1, Romain Martin1

  • 1Hôpital universitaire de Rangueil, service de médecine vasculaire, 1, avenue Jean-Poulhès, TSA 50032, 31059 Toulouse cedex 9, France.

Presse Medicale (Paris, France : 1983)
|January 27, 2018
PubMed
Summary
This summary is machine-generated.

Women face similar risks of lower-extremity artery disease (LEAD) as men, but their symptoms are often missed, leading to late diagnosis. Consequently, women experience higher complication rates after revascularization procedures.

More Related Videos

Point-Of-Care Ultrasound Screening for Proximal Lower Extremity Deep Venous Thrombosis
06:45

Point-Of-Care Ultrasound Screening for Proximal Lower Extremity Deep Venous Thrombosis

Published on: February 10, 2023

16.4K
Intravital Microscopy of Monocyte Homing and Tumor-Related Angiogenesis in a Murine Model of Peripheral Arterial Disease
08:38

Intravital Microscopy of Monocyte Homing and Tumor-Related Angiogenesis in a Murine Model of Peripheral Arterial Disease

Published on: August 26, 2017

7.6K

Related Experiment Videos

Last Updated: Feb 15, 2026

Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease
06:16

Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease

Published on: August 9, 2024

971
Point-Of-Care Ultrasound Screening for Proximal Lower Extremity Deep Venous Thrombosis
06:45

Point-Of-Care Ultrasound Screening for Proximal Lower Extremity Deep Venous Thrombosis

Published on: February 10, 2023

16.4K
Intravital Microscopy of Monocyte Homing and Tumor-Related Angiogenesis in a Murine Model of Peripheral Arterial Disease
08:38

Intravital Microscopy of Monocyte Homing and Tumor-Related Angiogenesis in a Murine Model of Peripheral Arterial Disease

Published on: August 26, 2017

7.6K

Area of Science:

  • Vascular Surgery
  • Peripheral Artery Disease Research
  • Gender Health Disparities

Background:

  • Lower-extremity artery disease (LEAD) affects both genders, but clinical presentation and outcomes may differ.
  • Underdiagnosis and delayed treatment in women can lead to advanced disease stages.
  • Existing research often overlooks gender-specific aspects of LEAD management.

Purpose of the Study:

  • To compare the risk, diagnosis, and treatment outcomes of LEAD in women versus men.
  • To highlight potential disparities in medical care and revascularization outcomes for female patients.
  • To emphasize the need for gender-sensitive approaches in managing peripheral artery disease.

Main Methods:

  • Review of epidemiological data on LEAD prevalence in men and women.
  • Analysis of diagnostic patterns and symptom presentation across genders.
  • Comparative study of morbidity rates following revascularization procedures in male and female cohorts.

Main Results:

  • Women exhibit a risk of LEAD comparable to men.
  • LEAD symptoms in women are frequently absent, atypical, or underestimated, resulting in diagnosis at later disease stages.
  • Women demonstrate a higher morbidity rate than men post-revascularization, irrespective of disease severity or procedure type.

Conclusions:

  • Gender-specific considerations are crucial for timely LEAD diagnosis and effective management.
  • Current medical care pathways may not be optimally adapted for women with LEAD.
  • Addressing gender disparities in LEAD care is essential to improve revascularization outcomes for women.